LINAC spend cuts New Zealand's radiotherapy waits - more to come:
This article was originally published in Clinica
New Zealand has reported a drop in post-operative radiology waiting times from 18 weeks to 12, thanks in large measure to its investment in linear accelerators, but the government acknowledges that more needs to be done. "New LINACs are being provided on a rolling programme," said the minister of health, Annette King, adding that: "New Zealand's cancer infrastructure remains fragile because of the time it takes to train staff." The success of the programme is being attributed mainly to the NZ$40m investment of the first phase of the Cancer Control Strategy Action Plan (see Clinica No 1156, p 14). A measure of its success is that patients are not having to be sent to Australia for radiotherapy.
You may also be interested in...
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.